While these results should only be cautiously extrapolated to arthroplasty procedures, a previous case–control study by Hurbanek et al. found no increased risk of venous thromboembolism following hip or knee arthroplasty among women taking HRT or selective estrogen receptor modulators [7]. The gene discussed is ESR1; the disease is venous thromboembolism.